Trent Basarsky

Trent Basarsky is an accomplished professional with extensive experience in corporate development and strategic advisory roles within the life sciences and technology sectors. Currently serving as a Strategic Advisor at RedWave Technology since June 2023, Trent contributes to the development of portable FTIR analyzers for chemical threat detection. Previously, Trent held key positions at 908 Devices, where innovative platforms such as REBEL and ZipChip were developed, leading to a successful IPO in December 2020. Other notable roles include Chief Business Officer at Zephyrus Biosciences, Vice President at ProteinSimple, and Director positions at Codexis and Molecular Devices, with a focus on acquisitions and business strategy. Educational credentials include a Ph.D. in Neuroscience from Iowa State University, a postdoctoral fellowship from the University of Calgary, and a BSc in Zoology & Cell Biology from the University of Alberta.